04 Intervention and Control

As evident in the COVID-19 pandemic, a substantial challenge in managing epidemics is the duration of the application of non-pharmaceutical interventions (NPIs), especially those that disrupt “normal” societal organization and function such as social distancing. These measures quickly become infeasible as pandemic fatigue builds.

  • As pharmaceutical interventions (PIs) such as vaccines, antiviral, or antimicrobial therapies become available, their gradual deployment, concurrently with a potential weakening of the NPIs, raises organizational challenges; uncertainty about vaccine or antimicrobial efficacy or potential for vaccine waning further complicates the issue, as do potential viral evolutions in response to the use of therapeutic tools. COVID-19 has highlighted the need for novel approaches using a One Health (OH) and the following projects aim to do just that.

Tags: Travel

RELATED ARTICLESExplain
EIDM 
Networks
OMNI
OMNI – Research
04 Intervention and Control
Advancing agent-based simulation scalability
Evolution of the virus: variants, transmission bottlenecks and fitness
Implementation of mobility restrictions
Mathematical modelling of human response behaviour during pandemics
Vaccination and antimicrobials, from the individual to the population
Covid-19
Vaccination
Nonpharmaceutical Interventions (NPIs)
01 Data Management
02 Risk for Emergence & Spillover
03 Early Warning Systems of Infectious Diseases
05 Indigenous Peoples Health and Wellbeing
Graph of this discussion
Enter the title of your article


Enter a short (max 500 characters) summation of your article
Enter the main body of your article
Lock
+Comments (0)
+Citations (0)
+About
Enter comment

Select article text to quote
welcome text

First name   Last name 

Email

Skip